Psychological and Social Impact of 6 Months Regular Methadone Treatment Program on a Sample of Chronic Relapsing Opioid Addicts

A Study of the Psychological and Social Impact of 6 Months Regular Methadone Treatment Program on a Sample of Chronic Relapsing Opioid Addicts

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202511695106803

Enrollment

Registered

2025-11-03

Start date

2025-02-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders

Interventions

Methadone

Usual treatment

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: -Male individuals aged above 18 years old (There is no female inpatient sector in ShubraKas Center for Addiction Treatment). -Opioid only addicted patients admitted to Shubra-Kas Center for Addiction Treatment. -Patient’s willingness to come daily to receive treatment -Patient able to give informed consent

Exclusion criteria

Exclusion criteria: -Patients with medical, neurological, and/ or other psychiatric comorbidities -Patient with hypersensitivity to methadone

Design outcomes

Primary

Measure	Time frame
Clinical Opiate Withdrawal Scale (COWS)	—

Secondary

Measure	Time frame
Short opiate withdrawal scale (SOWS);Ramsay Sedation Scale (RSS)	—

Countries

Egypt

Contacts

Public ContactAhmed Mobarak

Professor

ahmed_mubarak@med.tanta.edu.eg00201283549209

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026